最新一期业绩显示，2024年三季报，公司实现营业收入15.35亿元，同比-19.34%；净利润6691.31万元， 同比11.14%，销售毛利率8.65%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)18广聚能源91.7691.763.4595.09亿行业平均 11.6311.541.181658.85亿行业中值34.4738.341.5854.72亿1中晟高科-11.68-12.755.0919.71亿2茂化实 华-9.10-13.662.8117.47亿3沈阳化工-7.81-5.741.9226.31亿4国际实业-5.61-5.611.2224.61亿5博汇股份-3.82- 9.343.5718.95亿6*ST海越-3.00-3.470.308.52亿7华锦股份-2.81-2.810.6878.53亿8洲际油气 6.506.991.0888.79亿9ST新潮8.547.810.94202.65亿10中国海油8.598.591.5811844.46亿11中国石油 8.828.820.9614531.87亿 来源：金融界 4月21日，广聚能源今日收盘18.01元，上涨2.04%，滚动市盈率PE（当 ...

序号股票简称PE(TTM)PE(静)市净率总市值(元)26中电港52.7961.112.83144.61亿行业平均 64.6573.352.6884.97亿行业中值42.9458.182.0266.17亿1凯瑞德-7282.89856.4731.7716.10亿2天音控 股-402.92117.883.3198.61亿3利尔达-56.24-56.248.2861.81亿4赫美集团-53.63-78.896.6137.24亿5ST沪 科-45.87-46.1623.2510.16亿6*ST龙宇-32.2131.270.5820.62亿7汇鸿集团-26.98-66.671.2458.30亿8庚星股 份-15.46-27.338.8414.07亿9中成股份-11.80-17.698.7146.46亿10跨境通-11.26-11.266.3353.91亿11远大控 股-6.31-7.031.0426.52亿 本文源自：金融界 作者：行情君 资金流向方面，4月18日，中电港主力资金净流出2016.93万元，近5日总体呈流出状态，5日共流出 25042.97万元。 深圳中电港技术股份有限公司的主营业务是电子元器件分销业务 ...

序号股票简称PE(TTM)PE(静)市净率总市值(元)52龙源电力21.5821.581.871369.34亿行业平均 19.4020.482.17387.48亿行业中值17.0818.161.54135.22亿1华电辽能-893.591.809.5638.44亿2绿能慧 充-488.19301.749.8852.54亿3深南电A-377.951155.153.3948.04亿4郴电国际-78.14-78.140.7828.35亿5豫能 控股-50.77-50.771.9861.64亿6梅雁吉祥-48.43-58.682.6058.84亿7韶能股份-47.63-24.091.4364.08亿8华银电 力-41.17-38.095.8071.29亿9大连热电-17.83-17.836.4626.02亿10晋控电力-11.63-15.831.4181.54亿11*ST旭 蓝-2.06-4.140.077.29亿 本文源自：金融界 作者：行情君 龙源电力集团股份有限公司的主营业务是风力、光伏发电。公司的主要产品是电力、热力。 最新一期业绩显示，2024年年报，公司实现营业收入370.70亿元，同比-2.58%；净利 ...

截至2024年三季报，共有51家机构持仓成都先导，其中基金51家，合计持股数513.56万股，持股市值 0.63亿元。 来源：金融界 成都先导药物开发股份有限公司主营业务是DEL技术相关的药物早期发现研发服务，公司的主要服务主 要包含DEL筛选服务,DEL库定制,FBDD/SBDD,新药定制开发,化合物结构知识产权转让及化学合成等其 他新药研发相关服务等。 4月16日，成都先导今日收盘14.23元，下跌1.86%，滚动市盈率PE（当前股价与前四季度每股收益总和 的比值）达到111.94倍，总市值57.02亿元。 最新一期业绩显示，2024年三季报，公司实现营业收入2.98亿元，同比21.38%；净利润3012.03万元， 同比64.71%，销售毛利率49.34%。 从行业市盈率排名来看，公司所处的医疗服务行业市盈率平均45.05倍，行业中值46.97倍，成都先导排 名第39位。 序号股票简称PE(TTM)PE(静)市净率总市值(元)39成都先导111.94111.944.1457.02亿行业平均 45.0541.013.36141.40亿行业中值46.9735.682.4248.61亿1普瑞眼科-185.64 ...

Company Overview - Zhejiang Tailin Biological Technology Co., Ltd. specializes in the research, production, and sales of microbiological detection systems, environmental biological pollution control equipment, and total organic carbon analyzers [1] - The main products include various consumables, instruments, and equipment related to microbiological detection technology, isolation technology, and sterilization technology [1] - The company has been awarded the "Advanced Collective in Technological Innovation" by the China Pharmaceutical Equipment Industry Association [1] Financial Performance - As of the latest Q3 2024 report, the company achieved an operating income of 242 million yuan, representing a year-on-year increase of 19.37% [1] - The net profit for the same period was 11.31 million yuan, showing a year-on-year decrease of 46.91% [1] - The sales gross margin stood at 47.91% [1] Market Position - The company's current stock price is 16.79 yuan, with a decline of 2.78% [1] - The rolling price-to-earnings (PE) ratio is 210.40, significantly higher than the industry average of 45.94 and the industry median of 29.64 [1][2] - Tailin Biological ranks 115th in terms of PE ratio within the medical device industry [1] Institutional Holdings - As of the latest report, 39 institutions hold shares in Tailin Biological, all of which are funds, with a total holding of 650,300 shares valued at 1.1 million yuan [1]

Group 1 - The core viewpoint of the articles highlights the performance and valuation of Zhend Medical, which closed at 20.72 yuan with a PE ratio of 26.89 times, significantly lower than the industry average of 45.71 times [1][2] - Zhend Medical's total market capitalization is reported at 5.521 billion yuan, ranking 66th in the medical device industry based on PE ratio [1][2] - As of the third quarter of 2024, 181 institutions hold shares in Zhend Medical, with a total holding of 20.3871 million shares valued at 448 million yuan [1] Group 2 - The main business of Zhend Medical includes the production, research, and sales of medical dressings, with key products in wound care, surgical infection control, and pressure treatment [1] - The latest financial results for the third quarter of 2024 show Zhend Medical achieved operating revenue of 3.125 billion yuan, a year-on-year decrease of 2.61%, while net profit was 307 million yuan, an increase of 2.31%, with a gross profit margin of 34.84% [1]

最新一期业绩显示，2024年年报，公司实现营业收入28.76亿元，同比47.99%；净利润2982.62万元，同 比282.80%。 序号股票简称PE(TTM)PE(静)市净率总市值(元)20弘业期货295.99295.994.7088.28亿行业平均 39.1341.542.89197.24亿行业中值19.5224.971.38175.95亿1爱建集团-63.6081.500.6581.09亿2*ST仁 东-26.84-28.50113.0361.37亿3翠微股份-10.00-10.652.5462.22亿4江苏金租10.4011.131.27295.99亿5陕国投 A12.5912.590.96171.32亿6越秀资本13.6013.601.04312.07亿7五矿资本16.2810.880.57245.59亿8国网英大 16.3719.991.28272.77亿9南华期货17.0517.051.9078.09亿10海德股份18.7613.392.18117.86亿11中油资本 19.4619.460.89905.17亿 本文源自：金融界 作者：行情君 4月14日，弘业期货今日收盘8.76元，上涨5.93 ...

Group 1 - The core viewpoint of the article highlights that Beibu Gulf Port's stock price closed at 10.8 yuan, marking a 3.05% increase, with a rolling PE ratio of 20.18, the lowest in 728 days, and a total market capitalization of 24.598 billion yuan [1] - The average PE ratio for the shipping and port industry is 14.54, with a median of 14.67, placing Beibu Gulf Port at the 27th position in the industry ranking [1] - As of the Q3 2024 report, 101 institutions hold shares in Beibu Gulf Port, with a total of 18.8592 million shares valued at 149 million yuan [1] Group 2 - Beibu Gulf Port's main business activities include container and bulk cargo handling, storage, and port services, with key operations in port loading and unloading, tugboat services, cargo surveying, and agency services [1] - The latest performance report for Q3 2024 shows that the company achieved an operating revenue of 4.902 billion yuan, a year-on-year increase of 0.13%, and a net profit of 916 million yuan, reflecting a year-on-year increase of 8.06%, with a sales gross margin of 31.09% [1]

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Lehui International, indicating a significant decline in revenue while maintaining a positive net profit margin [1][2] - As of April 11, Lehui International's stock closed at 21.9 yuan, down 2.88%, with a rolling PE ratio of 114.05, significantly higher than the industry average of 60.59 [1][2] - The company's total market capitalization is 2.643 billion yuan, ranking 228th in the specialized equipment industry based on PE ratio [1][2] Group 2 - Lehui International specializes in the research, production, and manufacturing of liquid food equipment, including beer brewing and packaging equipment, beverage pre-treatment and packaging machinery, and dairy packaging machinery [1] - The company’s beer brewing complete equipment has been recognized as a national champion product in the fifth batch of national-level manufacturing single champion demonstration enterprises and products [1] - For the third quarter of 2024, Lehui International reported a revenue of 947 million yuan, a year-on-year decrease of 15.41%, while net profit was 40.53 million yuan, reflecting a year-on-year increase of 9.41%, with a sales gross margin of 27.59% [1]

Company Overview - Chendian International's closing price is 6.45 yuan, down 2.57%, with a rolling PE ratio of 64.39 times and a total market value of 2.387 billion yuan [1] - The company ranks 74th in the electricity industry's average PE ratio of 19.18 times and median of 18.00 times [1] - As of September 30, 2024, the number of shareholders is 25,201, a decrease of 3,730 from the previous period, with an average holding value of 352,800 yuan and an average holding of 27,600 shares [1] Business Operations - Chendian International is engaged in power supply and water supply as its main businesses, while also involved in hydropower development, new energy development, comprehensive energy services, industrial gases, and wastewater treatment [1] - The company's main products and services include electricity sales, industrial gas sales, and tap water sales [1] Financial Performance - For the third quarter of 2024, the company reported operating revenue of 3.317 billion yuan, a year-on-year increase of 9.77% [1] - The net profit for the same period is 60.4556 million yuan, reflecting a year-on-year increase of 257.79% [1] - The sales gross margin stands at 14.20% [1]